Cargando…
miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
The role of miR-26a in cancer cells seemed controversial in previous studies. Until now, the role of miR-26a in gastric cancer remains undefined. In this study, we found that miR-26a was strongly downregulated in gastric cancer (GC) tissues and cell lines, and its expression levels were associated w...
Autores principales: | Deng, Min, Tang, Hai-lin, Lu, Xi-hong, Liu, Mei-yuan, Lu, Xiao-min, Gu, Yi-xue, Liu, Ji-fang, He, Zhi-min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756000/ https://www.ncbi.nlm.nih.gov/pubmed/24015269 http://dx.doi.org/10.1371/journal.pone.0072662 |
Ejemplares similares
-
miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)
por: He, Xi, et al.
Publicado: (2018) -
miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
por: Lei, Chao, et al.
Publicado: (2017) -
Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1
por: Xing, Shan, et al.
Publicado: (2021) -
miR-26b-5p promotes osteogenesis of bone mesenchymal stem cells via suppressing FGF21
por: Wang, Bin, et al.
Publicado: (2023) -
Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
por: Sun, Yang, et al.
Publicado: (2023)